Alvaro Hermida(@Info_Rares) 's Twitter Profile Photo

Termina ya este y a pesar de los🦠,ha sido muy interesante conocer las ultimas novedades en enf. . Y como siempre,buenos momentos rodeado de grandes profesionales y amig@s. Gracias Cristina,Laura y Jorge J Cebolla de Takeda_ES por vuestro apoyo y amabilidad

account_circle
Passage Bio(@Passage_Bio) 's Twitter Profile Photo

This week at the 19th Annual WORLDSymposium, we’re at Booth #100 ready to discuss the impact we're making in the lysosomal and rare disease space. Visit us to learn about the ways we’re hoping to make a difference for patients.

account_circle
Chiesi Global Rare Diseases(@ChiesiGRD) 's Twitter Profile Photo

We were excited to receive a WORLDSymposia New Treatment Award recognizing our work to develop a therapeutic option for people living with Fabry disease. Diego Ardigò, Head of R&D, shares a message of gratitude for the community. b.link/oqury314

account_circle
Julia Jamieson(@juliajamieson_) 's Twitter Profile Photo

Today, I had the opportunity to present my poster at the 19th Annual WORLDSymposium and watch my mentor, Frederick Ashby, present as a Platform Speaker! WORLDSymposia

Today, I had the opportunity to present my poster at the 19th Annual WORLDSymposium and watch my mentor, Frederick Ashby, present as a Platform Speaker! @WORLDSymposia
account_circle
Begin_NGS(@Begin_NGS) 's Twitter Profile Photo

We had an inspiring time convening with the founding & prospective members of the Begin_NGS consortium at . Thank you to all who accompany us in our journey to help end the diagnostic & therapeutic odysseys.

We had an inspiring time convening with the founding & prospective members of the @Begin_NGS consortium at #WORLDSymposia. Thank you to all who accompany us in our journey to help end the diagnostic & therapeutic odysseys.  
#EndTheDiagnosticOdyssey #genomics #raredisease
account_circle
Wang-LysoLab(@WangLysolab) 's Twitter Profile Photo

The clinical trial results for LYS-GM101 on were disappointing, but provided important lessons moving forward in designing for this neurodegenerative pediatric disease.

Thank you Arunabha Ghosh for presenting the results at

The clinical trial results for LYS-GM101 on #GM1gangliosidosis were disappointing, but provided important lessons moving forward in designing #clinicaltrials for this neurodegenerative pediatric disease.

Thank you @Metabolic_Manc for presenting the results at #worldsymposia
account_circle
Engage Health Inc.(@EngageHealthInc) 's Twitter Profile Photo

The @WORLDSymposium has released registration for 2024! Sign up now and get the early registration rates by January 5, 2024!Sign up here: worldsymposia.org/worldsymposium…

The @WORLDSymposium has released registration for 2024! Sign up now and get the early registration rates by January 5, 2024!Sign up here: worldsymposia.org/worldsymposium…

#WORLDSymposia #CareAboutRare #RareDisease
account_circle
CME Outfitters(@cmeoutfitters) 's Twitter Profile Photo

Dr. Neal Weinreb wants YOU 🫵 to join us in Orlando I for this morning’s breakfast symposium on ! The session begins in 15 minutes, so come fix a plate & grab your seat now!

account_circle
Maze Therapeutics(@MazeInBiotech) 's Twitter Profile Photo

Join us in Orlando as we present data from our first-in-human clinical trial of MZE001 to treat Pompe Disease, and preclinical work supporting the program’s advancement at the 2023 WORLDSymposia 2023. Presentation details below. businesswire.com/news/home/2023…

account_circle
Rare Disease Research Partners(@RD__RP) 's Twitter Profile Photo

RDRP and MPS Society UK, here for those with rare diseases will be presenting work on the emotional impacts of Fabry disease during the poster session today - Thursday 8th February. You'll find us at Kiosk 29, poster number 318. We look forward to seeing you there

RDRP and @MPSSocietyUK will be presenting work on the emotional impacts of Fabry disease during the #WORLDSymposia poster session today - Thursday 8th February.  You'll find us at Kiosk 29, poster number 318. We look forward to seeing you there #research #rarediseases #fabry
account_circle
Maze Therapeutics(@MazeInBiotech) 's Twitter Profile Photo

Today at WORLDSymposia we presented positive data from our first-in-human clinical trial of MZE001 to treat Pompe Disease - supporting advancement into our Phase 2 clinical trial in 2023. Details here: businesswire.com/news/home/2023…

Today at @WORLDSymposia we presented positive data from our first-in-human clinical trial of MZE001 to treat Pompe Disease - supporting advancement into our Phase 2 clinical trial in 2023. Details here:  businesswire.com/news/home/2023…
account_circle
Wang-LysoLab(@WangLysolab) 's Twitter Profile Photo

Aaaand that’s a wrap. The sixth of CHOC / CHOC Docs platform presentations at the 2024 is finished.

Also completed a commentary re: reliance of tx on industry. Shareholder value is NOT aligned w interests of pts and their families

Aaaand that’s a wrap. The sixth of @chocchildrens / @CHOCDocs platform presentations at the 2024 #worldsymposia is finished.

Also completed a commentary re: reliance of #raredisease tx on industry. Shareholder value is NOT aligned w interests of pts and their families
account_circle
Cyclo Therapeutics, Inc.(@Cyclodexpert) 's Twitter Profile Photo

A full house at to discuss innovations in lysosomal storage disorders like NPC. Thank you to Dr. Caroline Hastings for her oral presentation on our global Phase 3 study TransportNPC. It’s been a busy week!

$CYTH

A full house at #WORLDSymposia to discuss innovations in lysosomal storage disorders like NPC. Thank you to Dr. Caroline Hastings for her oral presentation on our global Phase 3 study TransportNPC. It’s been a busy week! 

$CYTH #NiemannPick #LysosomalDisease
account_circle